J. Grünberger

B. Saletu, J. Grünberger, L. Linzmayer, 1981, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.

Determination of pharmacodynamics of psychotropic drugs by psychometric analysis.

B. Saletu, J. Grünberger, 1980, Progress in neuro-psychopharmacology.

Treatment of the alcoholic organic brain syndrome with EMD 21657. A derivative of a pyritinolmetabolite: double-blind clinical, quantitative EEG and psychometric studies.

B. Saletu, J. Grünberger, J. Volavka, 1978, International pharmacopsychiatry.

Subject Index Vol. 24, 1991

John P. Harris, B. Saletu, J. Grünberger, 1990 .

Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users

J. Grünberger, L. Linzmayer, N. Loimer, 1992, Psychiatry Research.

Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry

P. Anderer, B. Saletu, J. Grünberger, 2005, Psychopharmacology.

Neurophysiological Aspects of Positive and Negative Schizophrenia and Therapeutic Consequences: Trials with Benzamides

P. Anderer, B. Saletu, J. Grünberger, 1998 .

J. Grünberger, L. Linzmayer, N. Loimer, 1991, The American Journal of Drug and Alcohol Abuse.

Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.

B. Saletu, J. Grünberger, L. Linzmayer, 1986, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels

O. Presslich, J. Grünberger, L. Linzmayer, 2005, Psychopharmacology.

Quantitative EEG, SPEM, and Psychometric Studies in Schizophrenics before and during Differential Neuroleptic Therapy

P. Anderer, B. Saletu, J. Grünberger, 1986, Pharmacopsychiatry.

Sleep laboratory study of a new antianxiety drug, alpidem: short-term trial

B. Saletu, J. Grünberger, M. Schultes, 1986 .

The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v.

B. Saletu, J. Grünberger, 1984, Human neurobiology.

Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses.

B. Saletu, J. Grünberger, J. Volavka, 1979, Arzneimittel-Forschung.

On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies

B. Saletu, J. Grünberger, R. Frey, 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.

J Grünberger, B Saletu, P. Anderer, 1987, International journal of clinical pharmacology research.

[Self-inflicted injury and self-mutilation in prisoners].

J. Grünberger, W. Sluga, 1969, Wiener medizinische Wochenschrift.

Experimental Contribution to the Evaluation of the Suicidal Risk of Depressive Patients

J. Grünberger, E. Ringel, G. Sonneck, 1976 .

Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.

B. Saletu, J. Grünberger, 1980, Progress in neuro-psychopharmacology.

Color vision deficiencies in the course of acute alcohol withdrawal

J. Grünberger, R. Frey, M. Dietzel, 1993, Biological Psychiatry.

Assessment of psychoactivity and pharmacodynamics of a cerebral vasodilating hexobendine-combination by quantitative electroencephalographic and psychometric analyses

B. Saletu, J. Grünberger, 1978 .

Fluvoxamine—A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients

B. Saletu, J. Grünberger, O. Arnold, 2005, Journal of Neural Transmission.

On the central effects of the GABA agonist fengabine: Psychometric and pharmaco‐EEG studies utilizing imaging methods

P. Anderer, B. Saletu, J. Grünberger, 1987 .

Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations.

B. Saletu, J. Grünberger, L. Linzmayer, 1986, Archives of gerontology and geriatrics.

Drawing Inferences about the Therapeutic Efficacy of Drugs in Patients from their CNS Effect in Normals: Comparative Quantitative Pharmaco-EEG and Clinical Investigations

B. Saletu, J. Grünberger, M. Saletu, 1979 .

On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia.

P. Anderer, B. Saletu, J. Grünberger, 1996, British journal of clinical pharmacology.

Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).

P. Anderer, B. Saletu, J. Grünberger, 1994, Neuropsychobiology.

Testing Drugs for Impaired Brain Function in Old Age: On the Effects of a Single Dose of Bifemelane using Topographic Mapping of EEG and Event‐Related Potentials (P300) and Psychometric Measurements in Healthy Elderly Subjects

H. Semlitsch, P. Anderer, B. Saletu, 1996 .

Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment.

P. Anderer, B. Saletu, J. Grünberger, 1995, Neuropsychobiology.

[Street noise and sleep: whole night somnopolygraphic, psychometric and psychophysiologic studies in comparison with normal data].

B. Saletu, J. Grünberger, R. Frey, 1989, Wiener Medizinische Wochenschrift.

Activation, Deactivation, Depression: Psychosomatic In-Patient Therapy

J. Grünberger, L. Linzmayer, P. Gathmann, 1985 .

Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.

Bernd Saletu, Peter Anderer, Josef Grünberger, 1994 .

EEG‐Brain mapping, psychometric and psychophysiological studies on central effects of kavain ‐ a kava plant derivative

P. Anderer, B. Saletu, J. Grünberger, 1989 .

EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.

H. Semlitsch, P. Anderer, B. Saletu, 1990, Neuropsychobiology.

The effect of biologically-active light on the noo- and thymopsyche and on psychophysiological variables in healthy volunteers.

J Grünberger, L Linzmayer, B Saletu, 1993, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.

P. Anderer, B. Saletu, J. Grünberger, 1993, Methods and findings in experimental and clinical pharmacology.

Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: electroencephalographic brain mapping and safety evaluation

P. Anderer, B. Saletu, J. Grünberger, 1988 .

Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study

H. Semlitsch, P. Anderer, B. Saletu, 1995, Psychopharmacology.

Examining Pharmaco EEG-Based Predictions about the Antidepressant Action of Pirlindol by Double Blind Clinical Trials

B. Saletu, J. Grünberger, L. Linzmayer, 1985 .

Effect-kinetics on brain protection of two codergocrine-mesylate preparations (Aramexe retard and Hydergine) by EEG mapping and psychometry under hypoxia.

P. Anderer, B. Saletu, J. Grünberger, 1994, Archives of gerontology and geriatrics.

Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.

J Grünberger, L Linzmayer, B Saletu, 1994, British journal of clinical pharmacology.

Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderly.

P. Anderer, B. Saletu, J. Grünberger, 1990, Archives of gerontology and geriatrics.

Topographic EEG Brain Maps and Mental Performance Under Hypoxia After Placebo and Pyritinol

P. Anderer, B. Saletu, J. Grünberger, 1989 .

Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: psychometric and psychophysiological data

B. Saletu, J. Grünberger, L. Linzmayer, 1988 .

Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.

B. Saletu, J. Grünberger, L. Linzmayer, 1986, International journal of clinical pharmacology, therapy, and toxicology.

[Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].

P. Anderer, B. Saletu, J. Grünberger, 1991, Fortschritte der Neurologie-Psychiatrie.

Receptor Test (Pupillary Dilatation after Application of 0.01% Tropicamide Solution) and Determination of Central Nervous Activation (Fourier Analysis of Pupillary Oscillations) in Patients with Alzheimer’s Disease

L. Pezawas, J. Grünberger, L. Linzmayer, 1999, Neuropsychobiology.

Pupillary dilatation test and Fourier analysis of pupillary oscillations in patients with multiple sclerosis

J. Grünberger, L. Linzmayer, H. Walter, 2005, European Archives of Psychiatry and Clinical Neuroscience.

Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).

P. Anderer, B. Saletu, J. Grünberger, 1988, Archives of gerontology and geriatrics.

Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.

B. Saletu, J. Grünberger, L. Linzmayer, 1984, Archives of gerontology and geriatrics.

Promoting Vigilance in Older People: Comparative Pharmaco-EEG and Psychometric Studies with Nicergoline by Oral and Intramuscular Administration

B. Saletu, J. Grünberger, 1986 .

Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia.

P. Anderer, B. Saletu, J. Grünberger, 1996, Methods and findings in experimental and clinical pharmacology.

Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.

P. Anderer, B. Saletu, J. Grünberger, 1996, Methods and findings in experimental and clinical pharmacology.

Quantitative pharmaco-EEG and performance after administration of brotizolam to healthy volunteers.

B. Saletu, J. Grünberger, L. Linzmayer, 1983, British journal of clinical pharmacology.

The Acute Drug Effect as Predictor of Therapeutic Outcome: Neurophysiological/ Behavioral Correlations during Anxiolytic Therapy of Alcoholics

B. Saletu, J. Grünberger, M. Saletu, 1982 .

Assessment of Pharmacodynamics of a New “Controlled-Release” Form of Diazepam (Valium® CR Roche) by Quantitative EEG and Psychometric Analysis in Neurotic Subjects

B. Saletu, J. Grünberger, R. Amrein, 1981, The Journal of international medical research.

CFF and Assessment of Pharmacodynamics: Role and Relationship to Psychometric, EEG and Pharmacokinetic Variables

B. Saletu, J. Grünberger, P. Berner, 1982 .

Traffic noise-induced sleep disturbances and their correction by an anxiolytic sedative, OX-373.

B. Saletu, J. Grünberger, 1981, Neuropsychobiology.

Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.

B. Saletu, J. Grünberger, L. Linzmayer, 1980, Arzneimittel-Forschung.

Sleep laboratory studies on single dose effects of suriclone.

P. Anderer, B. Saletu, J. Grünberger, 1990, British journal of clinical pharmacology.

Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS).

B. Saletu, J. Grünberger, L. Linzmayer, 1977, International journal of clinical pharmacology and biopharmacy.

Acute Blocking of Naloxone-Precipitated Opiate Withdrawal Symptoms by Methohexitone

O. Presslich, J. Grünberger, K. Lenz, 1990, British Journal of Psychiatry.

[Determination of the encephalotropic, psychotropic and pharmacodynamic properties of nicergoline by means of quantitative pharmacoelectroencephalography and psychometric analysis].

B. Saletu, J. Grünberger, L. Linzmayer, 1979, Arzneimittel-Forschung.

Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.

P. Anderer, B. Saletu, J. Grünberger, 1995, International journal of clinical pharmacology and therapeutics.

On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.

B. Saletu, J. Grünberger, R. Anderer, 1990, International journal of clinical pharmacology, therapy, and toxicology.

LETTER TO THE EDITOR. Non‐Specificity of Pupillary Dilation Response to Tropicamide in Dementia of Alzheimer's Type

J. Grünberger, P. Fischer, 1996 .

Biochemical, physical and psychological findings in patients suffering from cardiac neurosis.

J. Grünberger, H. Zapotoczky, A. Korn, 1985, Neuropsychobiology.

Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.

B. Saletu, J. Grünberger, L. Linzmayer, 1976, Current therapeutic research, clinical and experimental.

Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life.

B. Saletu, J. Grünberger, L. Linzmayer, 1985, Neuropsychobiology.

[Psychopathology of patients with delusions of ectoparasitic infestation].

J. Grünberger, L. Linzmayer, W. Gebhart, 1988, Der Nervenarzt.

Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.

B. Saletu, J. Grünberger, L. Linzmayer, 1983, International journal of clinical pharmacology, therapy, and toxicology.

On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.

B. Saletu, J. Grünberger, L. Linzmayer, 1989, International journal of clinical pharmacology, therapy, and toxicology.

Pharmacokinetic and ‐dynamic studies in elderlies with a potential antihypoxidotic/nootropic drug tenilsetam utilizing pharmaco‐EEG and psychometry

B. Saletu, J. Grünberger, H. Cepko, 1986 .

Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.

P. Anderer, B. Saletu, J. Grünberger, 1995, Arzneimittel-Forschung.

Prognosis of cardiac phobia.

D. Nutzinger, J. Grünberger, H. Zapotoczky, 1990, Psychopathology.

[Pupillometry in psychopharmacologic experiments].

B. Saletu, J. Grünberger, L. Linzmayer, 1986, Arzneimittel-Forschung.

Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.

P. Anderer, B. Saletu, J. Grünberger, 1997, Neuropsychobiology.

Habituation of skin conductance response in a methadone population.

J. Grünberger, L. Linzmayer, R. Jagsch, 1990, Drug and alcohol dependence.

Gastric acid secretion, serum-gastrin levels and psychomotor function under the influence of placebo, insulin-hypoglycemia, and/or bromazepam.

J. Grünberger, G. Stacher, H. Brunner, 1976, International journal of clinical pharmacology and biopharmacy.

Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.

B. Saletu, J. Grünberger, 1984, Methods and findings in experimental and clinical pharmacology.

Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: Quantitative EEG, psychometric and pharmacokinetic studies in man

B. Saletu, J. Grünberger, P. Rajna, 2005, Journal of Neural Transmission.

Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency.

J. Grünberger, L. Linzmayer, G. Saletu-Zyhlarz, 1998, Alcohol and alcoholism.